In general, disruption of the Nrf2/HO-1 pathway in asthma is accompanied by airway hyperresponsiveness, neutrophil and eosinophil infiltration, and increased mucus secretion. This evidence concerns the gene NFE2L2 and airway hyperresponsiveness.